Ultrasound brain zapper trial pulled before it even started
NCT ID NCT05089786
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study was designed to test the safety and feasibility of a focused ultrasound device called Exablate Neuro with a new Echo-Focusing feature for people with treatment-resistant brain disorders like essential tremor or depression. However, the trial was withdrawn before enrolling any participants, so no data or results are available. The goal was to see if this non-invasive technique could improve quality of life without surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Exablate Neuro Type 1.0 System with Echo Focusing (focused ultrasound device)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single ketamine infusion quiet the obsessive mind?
- Can a structured care pathway ease teen depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can a nasal spray break through tough depression?
- Could a new drug offer hope for Treatment-Resistant depression?
- Can improv comedy help tame OCD?